Reuters Health
Hirva Mamdani, M.D., member of the Thoracic Oncology and Phase I Therapeutics Program at the Barbara Ann Karmanos Cancer Institute comments on a new treatment strategy for small-cell lung cancer.
Click here to read the complete article.